Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.
Eligibility criteria
Qualifiers
Availability of enough tissue for histological and NGS analysis (at least 20 ng DNA).
Age greater than/equal to 18 years.
Disqualifiers
None
Trial design
Treatments tested in this trial
- NGS
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov